P551: A PHASE 3, RANDOMIZED, OPEN-LABEL STUDY EVALUATING THE SAFETY AND EFFICACY OF MAGROLIMAB IN COMBINATION WITH AZACITIDINE IN PREVIOUSLY UNTREATED PATIENTS WITH TP53-MUTANT ACUTE MYELOID LEUKEMIA. (23rd June 2022) - Daver, N. G.; Vyas, P.; Chao, M. P.; Xing, G.; Renard, C.; Ramsingh, G.; Sallman, D. A.; Wei, A. H.